Hoth Therapeutics, formerly known as HOTH, has undergone a significant transformation, officially rebranding as Rocket One Inc. and adopting the new ticker symbol "RKTO." This strategic pivot signifies a major shift in the company's core focus, moving from biotechnology into the burgeoning field of AI chip technology and advanced computing systems tailored for critical space and defense applications. This reorientation has been met with a strong positive market response, as evidenced by a substantial increase in its stock value during after-hours trading. The company's prior biotechnology endeavors will continue to operate as a fully owned subsidiary, ensuring that previous research and development efforts are maintained under the new corporate structure.

Rocket One Inc. Soars with New Identity and Space-Focused Innovation

In a significant corporate development on May 28, 2026, Hoth Therapeutics officially commenced trading under its new name, Rocket One Inc., and the ticker symbol "RKTO" on the NASDAQ exchange. This strategic rebranding, which became effective after the close of trading on May 27, marks a decisive entry into the high-growth sector of space technology and defense. The newly christened Rocket One Inc. is channeling its efforts into cutting-edge artificial intelligence chip technology and sophisticated computing systems designed for the unique demands of satellites and low-Earth orbit systems.

A cornerstone of this new direction is the company's acquisition of exclusive rights to state-of-the-art nanomagnetic AI chip technology. This innovative technology is specifically engineered for low-power consumption and boasts high radiation tolerance, making it ideal for the harsh conditions of space environments. These advanced chips are set to revolutionize applications in satellite communication, defense infrastructure, and the processing of complex AI workloads in orbital settings. Meanwhile, the company's legacy biotechnology programs will persist as a wholly-owned subsidiary, ensuring continuity and further development in that domain.

The market's reaction to this rebranding and strategic shift has been notably enthusiastic. Hoth Therapeutics' shares experienced a remarkable 92.01% increase during Tuesday's regular trading session, closing at $1.36. This upward momentum continued into after-hours trading, where the stock surged an additional 27.94% to reach $1.74. With a market capitalization of approximately $25.95 million and a 12-month stock appreciation of 60%, Rocket One Inc. is poised for significant growth. Despite previous negative short, medium, and long-term price trends, this bold strategic move and focus on the orbital economy appear to be revitalizing investor confidence.

The transformation of Hoth Therapeutics into Rocket One Inc. offers a compelling narrative of corporate agility and strategic foresight. In an era where technological innovation is paramount, the company's pivot towards AI and space applications demonstrates a keen understanding of emerging market opportunities. This shift highlights the potential for companies to redefine their missions and leverage new technologies to drive growth and create value in dynamic industries. It also underscores the increasing convergence of disparate technological fields, where advancements in AI can profoundly impact sectors like aerospace and defense. This strategic reorientation may serve as a valuable case study for other firms seeking to adapt and thrive in an ever-evolving global economy.